Medical Condition News

RSS

ACS Chemical Biology report supports zebrafish for drug development

By combining the tools of medicinal chemistry and zebrafish biology, a team of Vanderbilt investigators has identified compounds that may offer therapeutic leads for bone-related diseases and cancer.

22 Jan 2010

NCD calls for policymakers to proactively address shortages in disability workforce infrastructure

The National Council on Disability (NCD) today released a report titled Workforce Infrastructure in Support of People with Disabilities: Matching Human Resources to Service Needs, calling for policymakers at all levels of government to proactively address current shortages and examine how labor market changes are driving both current and future supply.

22 Jan 2010

Seven-time PGA TOUR winner designates funds to the National Fragile X Foundation

Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.

22 Jan 2010

Combat injuries are not the leading cause of medical evacuation from war zones

The most common reasons for medical evacuation of military personnel from war zones in Iraq and Afghanistan in recent years have been fractures, tendonitis and other musculoskeletal and connective tissue disorders, not combat injuries, according to results of a Johns Hopkins study published January 22 in The Lancet.

22 Jan 2010

The American Journal of Pathology: Highlights from February 2010 issue

A group led by Dr. Peter Lloyd Jones at the University of Dundee, Dundee, Scotland; the University of Colorado Denver, Aurora, CO; and the University of Pennsylvania, Philadelphia, PA has demonstrated that tenascin-C affects proto-oncogene function in breast cancer. Their report can be found in the February 2010 issue of The American Journal of Pathology.

22 Jan 2010

Postdoctoral scientists receive prestigious award; grants totaling $1.54 million will help in funding innovative projects

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting exceptional early career researchers and innovative cancer research, named 11 new Damon Runyon Fellows at its November 2009 Fellowship Award Committee review.

22 Jan 2010

Norepinephrine responses to bucindolol influenced by alpha-2C adrenergic receptor genotype

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that the paper “An alpha-2C-Adrenergic Receptor Polymorphism Alters the Norepinephrine Lowering Effects and Therapeutic Response of the Beta Blocker Bucindolol in Chronic Heart Failure” was published in the January 2010 edition of the peer-reviewed journal Circulation: Heart Failure (http://circheartfailure.ahajournals.org).

22 Jan 2010

Researchers discover genetic variations that predict clinical outcomes in patients with stomach cancer

Researchers at the University of Southern California (USC) have, for the first time, identified specific genetic variations that predict clinical outcomes in patients with gastric (stomach) cancer.

22 Jan 2010

Fluctuation in insulin delivery due to pump movement may increase risk of complications in diabetics

Researchers at Sansum Diabetes Research Institute and University of California, Santa Barbara have concluded that changing the height of a conventional insulin pump in relation to its tubing and infusion set can significantly impact expected insulin delivery rates. Such changes can occur during routine daily activities like dressing, sleeping or showering.

22 Jan 2010

Physicians take measures to treat ADHD on college campuses across the country

In college, students with attention deficit/hyperactive disorder face an array of challenges—long days and nights of classes, studying and activities, all of which require increasing amounts of concentration.

22 Jan 2010

Researchers to study the impact of asthma on sleep and academic performance of young children

Bradley Hasbro Children's Research Center and Hasbro Children's Hospital researchers have received more than $2.5 million in direct costs from The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to study the impact of asthma on the sleep quality and academic performance of young children.

22 Jan 2010

Vitamin D insufficiency associated with higher risk of relapse attacks in patients with MS

Low vitamin D blood levels are associated with a significantly higher risk of relapse attacks in patients with multiple sclerosis (MS) who develop the disease during childhood, according to a study conducted by researchers from the University of California, San Francisco.

22 Jan 2010

Large New York medical center reduces CT scans and radiation dose delivered to patients with PE

A large New York medical center reduced the number of CT scans and radiation dose delivered to emergency department patients with suspected pulmonary emboli (PE) by holding collaborative educational seminars for staff and routing patients to CT pulmonary angiography (CTPA) or ventilation perfusion (V/Q) scanning based solely on their chest X-ray results, according to a study published in the February issue of the American Journal of Roentgenology.

22 Jan 2010

HealthPartners Medical Group to provide timely colorectal cancer screening for African American patients

HealthPartners Medical Group today announced that it has launched an initiative aimed at saving lives by providing more timely colorectal cancer screening for African American patients.

22 Jan 2010

Researchers identify new therapeutic approach for stroke treatment

For the first time, research led by Youming Lu, PhD, MD, Professor of Neurology and Neuroscience at LSU Health Sciences Center New Orleans School of Medicine, has identified a novel mechanism that may trigger brain damage during stroke and identified a therapeutic approach to block it.

22 Jan 2010

NicOx receives EMEA approval for naproxcinod MAA

NicOx S.A. today announced that the European Medicines Agency (EMEA) has validated the Marketing Authorization Application (MAA) for naproxcinod, which was submitted through the centralized procedure in December 2009. NicOx is seeking approval for an indication for the relief of the signs and symptoms of primary osteoarthritis. This follows the acceptance for filing of a New Drug Application (NDA) by the US Food and Drug Administration (FDA) in November 2009.

22 Jan 2010

CMO to manufacture Gaia BioPharma's GAI-122 Mitochondria-targeted neuroprotective agent

AlphaRx Inc. announced today that its licensee, Gaia BioPharma Limited, has signed an agreement with a contract manufacturing organization (CMO), to manufacture GAI-122 for use in the planned Phase I and II clinical trials of that product candidate. GAI-122 is being developed as I.V. administered formulation of an intracellular neuroprotectant that employs AlphaRx's proprietary nano-emulsion formulation technology.

22 Jan 2010

CDA to host skin cancer awareness event at Winnipeg

Winnipeg dermatologists are inviting members of the public to a skin cancer awareness event at Polo Park Shopping Centre's Community Centre, Winnipeg, on Monday January 25, 2010, from 10 am to 1.30 pm.

22 Jan 2010

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

22 Jan 2010

Panel discussion on benefits of oral chemotherapy in cancer care

US Oncology, Inc. partnered with the Association of Community Cancer Centers, Association of Oncology Social Work, American Society for Clinical Oncology, Community Oncology Alliance, Oncology Nursing Society and the National Patient Advocate Foundation in hosting a panel discussion on Capitol Hill today to examine the benefits of oral chemotherapy in cancer care, as well as challenges in its prescribing, accessibility and adherence in the current health care system.

22 Jan 2010

Medical Condition News

ACS Chemical Biology report supports zebrafish for drug development

NCD calls for policymakers to proactively address shortages in disability workforce infrastructure

Seven-time PGA TOUR winner designates funds to the National Fragile X Foundation

Combat injuries are not the leading cause of medical evacuation from war zones

The American Journal of Pathology: Highlights from February 2010 issue

Postdoctoral scientists receive prestigious award; grants totaling $1.54 million will help in funding innovative projects

Norepinephrine responses to bucindolol influenced by alpha-2C adrenergic receptor genotype

Researchers discover genetic variations that predict clinical outcomes in patients with stomach cancer

Fluctuation in insulin delivery due to pump movement may increase risk of complications in diabetics

Physicians take measures to treat ADHD on college campuses across the country

Researchers to study the impact of asthma on sleep and academic performance of young children

Vitamin D insufficiency associated with higher risk of relapse attacks in patients with MS

Large New York medical center reduces CT scans and radiation dose delivered to patients with PE

HealthPartners Medical Group to provide timely colorectal cancer screening for African American patients

Researchers identify new therapeutic approach for stroke treatment

NicOx receives EMEA approval for naproxcinod MAA

CMO to manufacture Gaia BioPharma's GAI-122 Mitochondria-targeted neuroprotective agent

CDA to host skin cancer awareness event at Winnipeg

AKD Global announces new class of cancer treatments in development

Panel discussion on benefits of oral chemotherapy in cancer care

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Latest News